Adult; Age Factors; Aged; Democratic Republic of the Congo/epidemiology; Female; HIV Infections/diagnosis/drug therapy/epidemiology; Humans; Retrospective Studies; Risk Factors; HIV care; Kinshasa; Late presentation
Abstract :
[en] INTRODUCTION: Late presentation for HIV care is a well-described issue for the success of ART outcomes and the cause of higher morbidity, mortality and further transmission. Monitoring the level of late presentation and understanding the factors associated with it would help to tailor screening and information strategies for better efficiency. We performed a retrospective cohort study in Kinshasa, the capital of the DRC. The studied population included HIV-positive adults newly enrolled in HIV care between January 2006 and June 2020 at 25 HIV urban care facilities. Patient information collected at presentation for HIV care included age, sex, WHO clinical stage and screening context. We used 2 definitions of late presentation: the WHO definition of advanced HIV disease (WHO stage 3/4 or CD4 cell count < 200 cells/mm(3)) and a more inclusive definition (WHO stage 3/4 or CD4 cell count < 350 cells/mm(3)). RESULTS: A total of 10,137 HIV-infected individuals were included in the analysis. The median age was 40 years; 68% were female. A total of 45.9% or 47.5% of the patients were late presenters, depending on the definition used. The percentage of patients with late presentation (defined as WHO stage 3/4 or CD4 cell count < 350 cells/mm(3)) decreased during recent years, from 70.7% in 2013 to 46.5% in 2017 and 23.4% in 2020. Age was associated with a significantly higher risk of LP (p < 0.0001). We did not observe any impact of sex. CONCLUSIONS: The frequency of late presentation for care is decreasing in Kinshasa, DRC. Efforts have to be continued. In particular, the issue of late diagnosis in older individuals should be addressed.
Disciplines :
Immunology & infectious disease
Author, co-author :
Ngongo, Nadine Mayasi
Nani-Tuma, Hippolyte Situakibanza
Mambimbi, Marcel Mbula
Mashi, Murielle Longokolo
Izizag, Ben Bepouka
Ndolumingu, Faustin Kitetele
Maes, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Service des informations médico-économiques > Appui à la recherche clinique et bistatistique
Moutschen, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses
Darcis, Gilles ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service des maladies infectieuses
Language :
English
Title :
Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020.
Rodger AJ, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–38. DOI: 10.1016/S0140-6736(19)30418-0
Darcis G, Berkhout B, Pasternak AO. Differences in HIV markers between infected individuals treated with different ART regimens: implications for the persistence of viral reservoirs. Viruses. 2020. 10.3390/v12050489. DOI: 10.3390/v12050489
World Health Organization, World Health Organization, & Department of HIV/AIDS. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV; 2015. http://apps.who.int/iris/bitstream/handle/10665/186275/9789241509565_eng.pdf;jsessionid=8D92E5DD362283D7376E4440F782540E?sequence=1. Accessed 31 Mar 2021.
World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy; 2017. https://apps.who.int/iris/bitstream/handle/10665/255884/9789241550062-eng.pdf?sequence=1. Accessed 31 Mar 2021.
Blaizot S, et al. Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study. Dis BMC Infect. 2016. 10.1186/s12879-016-1520-4. DOI: 10.1186/s12879-016-1520-4
Blankley S, et al. Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe. PLOS One. 2019;14:e0214739. DOI: 10.1371/journal.pone.0214739
Silverman RA, et al. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: a prospective cohort study. PloS one. 2019. 10.1371/journal.pone.0223411. DOI: 10.1371/journal.pone.0223411
Global AIDS Update. Seizing the moment, Tackling entrenched inequalities to end epidemics; 2020. https://www.unaids.org/en/resources/documents/2020/global-aids-report. Accessed 31 Mar 2021.
Lundgren JD, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807. DOI: 10.1056/NEJMoa1506816
Robbins GK, et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009;48:350–61. DOI: 10.1086/595888
Lebelonyane R, et al. Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes. AIDS Lond Engl. 2020;34:2223–30. DOI: 10.1097/QAD.0000000000002627
Deng K, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 2015;517:381–5. DOI: 10.1038/nature14053
Ait-Ammar A, et al. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front Microbiol. 2020. 10.3389/fmicb.2019.03060. DOI: 10.3389/fmicb.2019.03060
Darcis G, et al. Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017. Sci Rep. 2018;8:8594. DOI: 10.1038/s41598-018-26852-0
Belay GM, Endalamaw A, Ayele AD. Late presentation of HIV positive adults and its predictors to HIV/AIDS care in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19:534. DOI: 10.1186/s12879-019-4156-3
Komninakis SV, Mota ML, Hunter JR, Diaz RS. Late Presentation HIV/AIDS Is Still a Challenge in Brazil and Worldwide. AIDS Res Hum Retroviruses. 2018;34:129–31. DOI: 10.1089/aid.2015.0379
Wilton J, et al. Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999–2013). HIV Med. 2019;20:110–20. DOI: 10.1111/hiv.12686
Raffetti E, et al. The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort. BMC Public Health. 2016;16:878. DOI: 10.1186/s12889-016-3477-z
Late presenters working group in COHERE in EuroCoord, et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2015;20:30070.
Antinori A, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12:61–4. DOI: 10.1111/j.1468-1293.2010.00857.x
Ngongo NM, et al. Progressive phasing out of baseline CD4+ cell count testing for people living with HIV in Kinshasa, Democratic Republic of the Congo. AIDS Lond Engl. 2021;35:841–3. DOI: 10.1097/QAD.0000000000002802
Gesesew HA, et al. Significant association between perceived HIV related stigma and late presentation for HIV/AIDS care in low and middle-income countries: a systematic review and meta-analysis. PloS One. 2017;12:e0173928. DOI: 10.1371/journal.pone.0173928
Darling KE, et al. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss Med Wkly. 2016;146:w14348.
Chkhartishvili N, et al. Late presentation of HIV infection in the country of Georgia: 2012–2015. PLoS One. 2017. 10.1371/journal.pone.0186835. DOI: 10.1371/journal.pone.0186835
Molina J-M, et al. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Lancet HIV. 2018;5:e172–80. DOI: 10.1016/S2352-3018(18)30003-1
Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case-control study. AIDS Res Ther. 2011;8:8. DOI: 10.1186/1742-6405-8-8